Your request to link to rcsb for Carbonic anhydrase 1


  • 1CRM: structure and function of carbonic anhydrases
  • 1CZM: drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i (10.1006/JMBI.1994.1655 )
  • 1HCB: enzyme-substrate interactions: structure of human carbonic anhydrase i complexed with bicarbonate (10.1006/JMBI.1994.1491 )
  • 1HUG: differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes unpublished results) and refined structure of the title (10.1107/S0907444994001873 )
  • 1HUH: differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes unpublished results) and refined structure of the title (10.1107/S0907444994001873 )
  • 1J9W: solution structure of the cai michigan 1 variant (10.1021/BI0120446 )
  • 1JV0: the crystal structure of the zinc(ii) adduct of the cai michigan 1 variant (10.1021/BI0120446 )
  • 2CAB: structure, refinement and function of carbonic anhydrase isozymes. refinement of human carbonic anhydrase i
  • 2FOY: human carbonic anhydrase i complexed with a two-prong inhibitor (10.1021/JA057257N )
  • 2FW4: carbonic anhydrase activators. the first x-ray crystallographic study of an activator of isoform i, structure with l-histidine. (10.1016/J.BMCL.2006.07.021 )
  • 2IT4: x ray structure of the complex between carbonic anhydrase i and the phosphonate antiviral drug foscarnet (10.1016/J.BMCL.2007.01.113 )
  • 2NMX: structure of inhibitor binding to carbonic anhydrase i (10.1021/JA068359W )
  • 2NN1: structure of inhibitor binding to carbonic anhydrase i (10.1021/JA068359W )
  • 2NN7: structure of inhibitor binding to carbonic anhydrase i (10.1021/JA068359W )
  • 3LXE: human carbonic anhydrase i in complex with topiramate (10.1039/B926832D )
  • 3W6H: crystal structure of 19f probe-labeled hcai in complex with acetazolamide
  • 3W6I: crystal structure of 19f probe-labeled hcai
  • 4WR7: crystal structure of human carbonic anhydrase isozyme i with 2,3,5,6- tetrafluoro-4-(propylthio)benzenesulfonamide. (10.1016/J.BPC.2015.05.009 )
  • 4WUP: crystal structure of human carbonic anhydrase isozyme i with 4-[(2- hydroxyethyl)thio]benzenesulfonamide (10.1016/J.BPC.2015.05.009 )
  • 4WUQ: crystal structure of human carbonic anhydrase isozyme i with 2,3,5,6- tetrafluoro-4-piperidin-1-ylbenzenesulfonamide (10.1016/J.BPC.2015.05.009 )
  • 5E2M: crystal structure of human carbonic anhydrase isozyme i with 3- (cyclooctylamino)-2,5,6-trifluoro-4-[(2-hydroxyethyl) sulfonyl]benzenesulfonamide (10.1002/CMDC.201600509 )
  • 5GMM: crystal structure of human carbonic anhydrase i in complex with polmacoxib (10.1016/J.BBRC.2016.07.114 )
  • 6EVR: crystal structure of human carbonic anhydrase i in complex with the 4- (4 acetyl-3-benzylpiperazine-1 carbonyl)benzene-1-sulfonamide inhibitor (10.1016/J.EJMECH.2018.04.002 )
  • 6EX1: crystal structure of human carbonic anhydrase i in complex with the 4- [(3s)-3 benzyl-4-(4-sulfamoylbenzoyl)piperazine -1-carbonyl]benzene- 1-sulfonamide inhibitor (10.1016/J.EJMECH.2018.04.002 )
  • 6F3B: crystal structure of human carbonic anhydrase i in complex with the 1- (2-hydroxy-5-sulfamoylphenyl)-3-[(4-methylphenyl)methyl]urea inhibitor (10.1021/ACS.JMEDCHEM.8B00770 )
  • 6FAF: crystal structure of human carbonic anhydrase i in complex with the 3- (2,5-dimethylphenyl)-1-(2-hydroxy-5-sulfamoylphenyl)urea inhibitor (10.1021/ACS.JMEDCHEM.8B00770 )
  • 6FAG: crystal structure of human carbonic anhydrase i in complex with the 1- (2-hydroxy-5-sulfamoylphenyl)-3-(2-methoxyphenyl)urea inhibitor (10.1021/ACS.JMEDCHEM.8B00770 )
  • 6G3V: crystal structure of human carbonic anhydrase i in complex with the inhibitor famotidine (10.1021/ACSMEDCHEMLETT.8B00334 )
  • 6HWZ: selenols: a new class of carbonic anhydrase inhibitors (10.1039/C8CC08562E )
  • 6I0J: crystal structure of human carbonic anhydrase i in complex with the 4- ({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenyl sulfamate inhibitor (10.1016/J.EJMECH.2019.111600 )
  • 6I0L: crystal structure of human carbonic anhydrase i in complex with the 1- [4-chloro-3-(trifluoromethyl)phenyl]-3-[2-(4-sulfamoylphenyl) ethyl]urea inhibitor (10.1016/J.EJMECH.2019.111600 )
  • 6SWM: selenol bound carbonic anhydrase i (10.1039/C8CC08562E )
  • 6XZE: crystal structure of human carbonic anhydrase i in complex with 4-(3- (2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide (10.3390/IJMS21072560 )
  • 6XZO: crystal structure of human carbonic anhydrase i in complex with 4-(3- (2-((4-bromo-2-hydroxybenzyl)amino)ethyl)ureido) benzenesulfonamide (10.3390/IJMS21072560 )
  • 6XZS: crystal structure of human carbonic anhydrase i in complex with 4-(3- (2-((4-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide (10.3390/IJMS21072560 )
  • 6XZX: crystal structure of human carbonic anhydrase i in complex with 4-(3- (2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide (10.3390/IJMS21072560 )
  • 6XZY: crystal structure of human carbonic anhydrase i in complex with 4-(3- (2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide (10.3390/IJMS21072560 )
  • 6Y00: crystal structure of human carbonic anhydrase i in complex with 4-(3- (2-((2-fluorobenzyl)amino)ethyl)ureido) benzenesulfonamide (10.3390/IJMS21072560 )
  • 7Q0D: human carbonic anhydrase i in complex with methyl 2-(benzenesulfonyl)- 4-chloro-5-sulfamoylbenzoate (10.3390/IJMS23010130 )